Scorpion Therapeutics Enters Agreement With AstraZeneca To Discover, Develop And Commercialize Novel Cancer Treatments Against 'Undruggable' Targets; Scorpion Will Receive An Upfront Cash Payment Of $75M And Is Eligible To Receive Up To An Additional $1.5